B-cell and T-cell quantification in minor salivary glands in primary Sjögren’s syndrome: development and validation of a pixel-based digital procedure

BackgroundEvaluating lymphocytic infiltration of minor salivary gland biopsy in primary Sjögren’s syndrome is challenging. We developed and evaluated a digital method for quantifying B and T lymphocytes in whole minor salivary gland biopsy slides.MethodsMinor salivary gland biopsies were immunostained with anti-CD20/anti-CD3 antibodies using red/brown chromogens. Slides were digitised and spliced into mosaics of smaller JPEG format images in which red and brown pixels were counted. ImageJ Cell counter was used for validation. Agreement between the digital and manual methods was evaluated using Bland-Altman plots and the interclass correlation coefficient. External validation relied on the Chisholm-Mason, Tarpley, and focus-score methods.ResultsOf 62 minor salivary gland biopsy slides, 61.3 % had a Chisholm-Mason grade ≥ III or a focus score ≥1. The number of pixels correlated well with manual cell counts (r = 0.95 for red pixels vs. B cell count and r = 0.91 for brown pixels vs. T cell count). Interclass correlation coefficients between digital and manual counts were excellent (0.92 for B/T cells). B-cell proportion showed a significant positive correlation with the focus score (Spearman’s coefficient 0.463, p < 0.0001). Median B-cell proportion was lower in minor salivary gland biopsies with Chisholm grades I–II (2.5 % (0.2–13.9)) than III–IV (30.0 % (15.5–45.2)) and increased with Tarpley’s class (1, 2.2 % (0.2–6.6); 2, 27.2 % (13.0–38.9); and 3–4, 48.5 % (29.4–56.4); p < 0.001 for all comparisons). Minor salivary gland biopsy B-cell proportion was also significantly correlated with several markers of clinical and biological activity of the disease, especially with markers of systemic B-cell hyperactivation.ConclusionThe digital procedure proved accurate compared to the reference standard, producing reliable results for whole tissue sections.Trial registrationClinicalTrials.gov [NCT00740948]. Registered 22 August 2008.

[1]  D. Chisholm,et al.  Lymphocytic sialadenitis in the major and minor glands: a correlation in postmortem subjects , 1970, Journal of Clinical Pathology.

[2]  J. Mansfield,et al.  Multispectral imaging in biology and medicine: Slices of life , 2006, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[3]  Todd H. Stokes,et al.  Pathology imaging informatics for quantitative analysis of whole-slide images , 2013, Journal of the American Medical Informatics Association : JAMIA.

[4]  D. Chisholm,et al.  Labial salivary gland biopsy in Sjögren's disease , 1968, Journal of clinical pathology.

[5]  T Vrekoussis,et al.  Image analysis of breast cancer immunohistochemistry-stained sections using ImageJ: an RGB-based model. , 2009, Anticancer research.

[6]  X. Mariette,et al.  Treatment of Primary Sjgren Syndrome With Rituximab , 2014, Annals of Internal Medicine.

[7]  A. Tzioufas,et al.  Current aspects of pathogenesis in Sjögren’s syndrome , 2010, Therapeutic advances in musculoskeletal disease.

[8]  C. L. White,et al.  Minor salivary gland involvement in Sjögren's syndrome. , 1974, Oral surgery, oral medicine, and oral pathology.

[9]  H. Moutsopoulos,et al.  Characteristics of the minor salivary gland infiltrates in Sjögren's syndrome. , 2010, Journal of autoimmunity.

[10]  A. Tzioufas,et al.  Sjogren's syndrome: an update on clinical, basic and diagnostic therapeutic aspects. , 2012, Journal of autoimmunity.

[11]  L. Chiche,et al.  Blood and salivary-gland BAFF-driven B-cell hyperactivity is associated to rituximab inefficacy in primary Sjögren's syndrome. , 2016, Journal of autoimmunity.

[12]  J. Pers,et al.  BAFF Overexpression Is Associated with Autoantibody Production in Autoimmune Diseases , 2005, Annals of the New York Academy of Sciences.

[13]  R. Jonsson,et al.  The complexity of Sjögren's syndrome: novel aspects on pathogenesis. , 2011, Immunology letters.

[14]  J. Pers,et al.  Ectopic Germinal Centers Are Rare in Sjögren’s Syndrome Salivary Glands and Do Not Exclude Autoreactive B Cells1 , 2009, The Journal of Immunology.

[15]  J. Pers,et al.  Disturbance of cytokine networks in Sjögren's syndrome , 2011, Arthritis research & therapy.

[16]  R M Levenson,et al.  Quantification of immunohistochemistry—issues concerning methods, utility and semiquantitative assessment II , 2006, Histopathology.

[17]  L. Criswell,et al.  Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjögren's syndrome among 1,726 registry participants. , 2011, Arthritis and rheumatism.

[18]  J. Pers,et al.  Gene expression profile in the salivary glands of primary Sjögren's syndrome patients before and after treatment with rituximab. , 2010, Arthritis and rheumatism.

[19]  A. Saraux,et al.  Treatment of primary Sjögren syndrome with rituximab. In response. , 2014, Annals of internal medicine.

[20]  Mba Fds Rcs,et al.  Focal Adenitis in Salivary and Lacrimal Glands , 1963, Proceedings of the Royal Society of Medicine.

[21]  R. Jonsson,et al.  Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndrome , 2011, Annals of the rheumatic diseases.

[22]  Douglas G. Altman,et al.  Measurement in Medicine: The Analysis of Method Comparison Studies , 1983 .

[23]  R. Jonsson,et al.  Serological implications of germinal center-like structures in primary Sjögren's syndrome. , 2007, The Journal of rheumatology.

[24]  Richard M Levenson,et al.  Spectral imaging perspective on cytomics , 2006, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[25]  Joachim M. Buhmann,et al.  Computational Pathology: Challenges and Promises for Tissue Analysis , 2015, Comput. Medical Imaging Graph..

[26]  Hannu Kautiainen,et al.  Arthritis Research & Therapy , 2009 .

[27]  J. Pers,et al.  Diagnostic value of labial minor salivary gland biopsy for Sjögren's syndrome: a systematic review. , 2013, Autoimmunity reviews.

[28]  F. Ciccia,et al.  Is minor salivary gland biopsy more than a diagnostic tool in primary Sjögren׳s syndrome? Association between clinical, histopathological, and molecular features: a retrospective study. , 2014, Seminars in arthritis and rheumatism.

[29]  A. Saraux,et al.  Reliability of histopathological salivary gland biopsy assessment in Sjögren's syndrome: a multicentre cohort study. , 2015, Rheumatology.

[30]  R. Jonsson,et al.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group , 2002, Annals of the rheumatic diseases.

[31]  G. Baron,et al.  EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome , 2009, Annals of the rheumatic diseases.

[32]  H. Moutsopoulos,et al.  Foxp3+ T-regulatory cells in Sjogren's syndrome: correlation with the grade of the autoimmune lesion and certain adverse prognostic factors. , 2008, The American journal of pathology.

[33]  X. Mariette,et al.  Treatment of primary Sjögren syndrome with rituximab: a randomized trial. , 2014, Annals of internal medicine.

[34]  Renu Malhotra,et al.  IHC Profiler: An Open Source Plugin for the Quantitative Evaluation and Automated Scoring of Immunohistochemistry Images of Human Tissue Samples , 2014, PloS one.

[35]  J. Greenspan,et al.  The histopathology of Sjögren's syndrome in labial salivary gland biopsies. , 1974, Oral surgery, oral medicine, and oral pathology.

[36]  J. Pers,et al.  B cells in Sjögren's syndrome: from pathophysiology to diagnosis and treatment. , 2012, Journal of autoimmunity.

[37]  T. Daniels Labial salivary gland biopsy in Sjögren's syndrome. Assessment as a diagnostic criterion in 362 suspected cases. , 1984, Arthritis and rheumatism.